|

Risk Evaluation and Management in Heart Failure

RECRUITINGSponsored by Ruijin Hospital
Actively Recruiting
SponsorRuijin Hospital
Started2016-06
Est. completion2026-12
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT02998788

Summary

This is an prospective study conducted in a Chinese heart failure population. The study investigates the effects of cardiovascular disease risk factors such as lifestyle behaviors,biomarkers and intermediate diseases on heart failure prognosis.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* aged 18 and above
* inpatient with one of the following clinical situations:

  * congestive heart failure (pulmonary edema,pulmonary congestion or peripheral edema)
  * cardiogenic shock
  * Insufficient high output cardiac
* with impaired cardiac function diagnosed by echocardiography
* able to provide informed consent

Exclusion Criteria:

* expressed refusal to participate in the baseline investigation or follow-up visits Severe co-morbidity associated with a reduction in life expectancy of less than 12 months

Conditions3

Heart DiseaseHeart FailureRisk Factor, Cardiovascular

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.